Form 4: Alaunos Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Jaime Vieser, a Director of Alaunos Therapeutics, Inc., received 22,669 shares of common stock on October 6, 2026.
Summary
- Grant/award: acquired 22,669 Common Stock at $0.74 ($16,875) on October 6, 2026; holds 70,311 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jaime Vieser — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Grant/award | Common Stock | 22,669 | $1 | $16.9K | 70,311 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Grant/award (22,669 shares) |
Keywords
insider transaction, Form 4, TCRT, Alaunos Therapeutics, Inc., neutral, Jaime Vieser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.